Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

Bacterial Curli Amyloid: Researchers Examine the Role of Bacterial Infection in Lupus Pathology

Richard Quinn  |  June 3, 2016

New research has found that the amyloid protein curli triggers immune activation and autoantibody production in lupus-prone and wild-type mice. Stefania Gallucci, MD, says these results provide insight into the mechanisms of bacterial infection that may result in lupus…

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:bacteriaInfectionLupuspathologysystemic lupus erythematosus (SLE)

FDA Restricts Use of Systemic Fluoroquinolones Due to Side Effects & Will Review Application of Apadaz for Pain

Michele B. Kaufman, PharmD, BCGP  |  June 1, 2016

The FDA has issued new safety guidelines for systemic fluoroquinolones, restricting their use to patients with no alternative treatment options…

Filed under:AnalgesicsDrug Updates Tagged with:acetaminophenBenzhydrocodone hydrochlorideDrug SafetyFDAFood and Drug AdministrationPainsafety warningside effect

Rheumatology & Other Medical Residents Have High Risk of Depression

Richard Quinn  |  May 27, 2016

Over the past 40 years, the prevalence and risk of depression for medical residents has increased, according to research from Douglas A. Mata, MD, MPH, and colleagues. Addressing this phenomenon may be vital for the future of rheumatology and medicine…

Filed under:Career DevelopmentProfessional Topics Tagged with:Depressioneducation & trainingmedical residentMental Healthresidents

Osteoarthritis Treatments: Monoclonal Antibody Starts Clinical Trial & Fasinumab Promising for Treating Pain

Michele B. Kaufman, PharmD, BCGP  |  May 25, 2016

Recent clinical trials have evaluated the efficacy of GSK3196165, a monoclonal antibody, and fasinumab, a nerve growth factor antibody, in treating patients with osteoarthritis and pain…

Filed under:ConditionsDrug UpdatesOsteoarthritis and Bone Disorders Tagged with:fasinumabhandhand painKnee Osteoarthritis (OA)monoclonal antibodyosteoarthritis (OA)Pain

Doubts Mount over Merger of Health Insurers Anthem, Cigna

Bill Berkrot  |  May 24, 2016

(Reuters)—Wall Street expressed growing doubts about a pending $54 billion merger of U.S. health insurers Anthem Inc. and Cigna Corp. on Monday as news of management squabbles added to concerns over its review by antitrust regulators. Cigna shares closed down 4% at $126.15, well below Anthem’s original $188 per share offer of cash and stock…

Filed under:Legal Updates Tagged with:Anthem Inc.Cigna Corp.Health Insuranceinsurermerger

Baricitinib Has Promising Clinical Trial Results for Treating RA

Michele B. Kaufman, PharmD, BCGP  |  May 18, 2016

Recent clinical trials have shown that baricitinib is safe and effective for treating patients with rheumatoid arthritis who have proved non-responsive to multiple biologic treatments…

Filed under:Biologics/DMARDsDrug UpdatesRheumatoid Arthritis Tagged with:baricitinibclinical trialsJAK inhibitorsRheumatoid Arthritis (RA)

TNF Blocking Drugs Persist in Infants after Exposure In-Utero

Anne Harding  |  May 15, 2016

NEW YORK (Reuters Health)—Babies born to mothers who took anti-tumor necrosis factor (anti-TNF) agents during pregnancy have detectable drug in their bodies up to 12 months of age, new findings show. These infants should therefore not receive live vaccines during their first year of life, Dr. Mette Julsgaard of Aarhus University Hospital in Denmark and…

Filed under:Biologics/DMARDsDrug Updates Tagged with:adalimumabanti-TNF agentinfliximabpregnancyTNF

Drug Company Gifts Linked to Doctors’ Prescribing Habits

Andrew M. Seaman  |  May 15, 2016

(Reuters Health)—Doctors who receive payments or gifts from pharmaceutical companies are more likely to prescribe brand name medications, a new study suggests. Dr. James Yeh, of Brigham and Women’s Hospital in Boston, and colleagues write May 9 online in JAMA Internal Medicine that some states require doctors to report what they receive from drug companies….

Filed under:Drug UpdatesProfessional Topics Tagged with:generic drugsphysicianprescribePrescription drugsStatin

Preparing for Increased HIPAA Audits Among Smaller Rheumatology Providers

Steven M. Harris, Esq.  |  May 13, 2016

Recent enforcement activities of the Department of Health and Human Services’ Office for Civil Rights (OCR) have shown an increase in fines and penalties assessed against smaller providers for failing to comply with the privacy, security and breach notification requirements of the Health Insurance Portability and Accountability Act (HIPAA). Historically, OCR has focused on larger…

Filed under:Billing/CodingLegal UpdatesPractice Support Tagged with:AuditsHHSHIPAA complianceLegalnoncompliancephysician practicePractice Managementrheumatologist

Role of Dietitians in Rheumatology

Deanna Yamamoto, NP, on behalf of the ARHP Practice Committee  |  May 13, 2016

What do dietitians do to help manage patients with rheumatic disease? Dietitians are well integrated, for example, in the practice of nephrology and diabetes, but few are active in the specialty of rheumatology. However, dietitians are recognized as part of the team of providers designated to care for patients with rheumatic disease by the ACR….

Filed under:ConditionsPractice Support Tagged with:Dietdietitianpatient carerheumatology

  • « Previous Page
  • 1
  • …
  • 211
  • 212
  • 213
  • 214
  • 215
  • …
  • 323
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences